BioMarin-Amicus US antitrust deadline set to expire on Feb. 20; EU referral sought
BioMarin Pharmaceutical and Amicus Therapeutics have filed paperwork under the Hart-Scott-Rodino Act with the US antitrust authorities on Jan. 21, according to an Amicus US Securities and Exchange Commission filing. The...To view the full article, register now.
Already a subscriber? Click here to view full article